Rchr
J-GLOBAL ID:201801016575162080   Update date: May. 08, 2024

Hasegawa Naoyuki

ハセガワ ナオユキ | Hasegawa Naoyuki
Affiliation and department:
Job title: Assistant Professor
Research field  (1): Gastroenterology
Papers (49):
  • Abe, Ryo, Hasegawa, Naoyuki, Suzuki, Satoshi, Shigeta, Sakiko, Matsuoka, Ryota, Kato, Takayasu, Niisato, Yusuke, Seo, Emiko, Matsubara, Daisuke, Tsuchiya, Kiichiro. Simultaneous occurrence of autoimmune hepatitis and autoimmune hemolytic anemia after COVID-19 infection: case report and literature review. Clinical journal of gastroenterology. 2024
  • Fukuda, Satoshi, Hasegawa, Naoyuki, Mori, Kensaku, Kawai, Hitomi, Niisato, Yusuke, Endo, Masato, Seo, Emiko, Sakamoto, Noriaki, Matsubara, Daisuke, Tsuchiya, Kiichiro. Shrinkage of Enlarged Hepatic Nodules by an Embolizing Congenital Extrahepatic Portosystemic Shunt. Internal medicine (Tokyo, Japan). 2023
  • Iizumi, Takashi, Okumura, Toshiyuki, Hasegawa, Naoyuki, Ishige, Kazunori, Fukuda, Kuniaki, Seo, Emiko, Makishima, Hirokazu, Niitsu, Hikaru, Takahashi, Mizuki, Sekino, Yuta, et al. Proton beam therapy for hepatocellular carcinoma with bile duct invasion. BMC gastroenterology. 2023. 23. 1. 267-267
  • Shimomura, Osamu, Endo, Masato, Makishima, Hirokazu, Yamada, Takeshi, Hashimoto, Shinji, Numajiri, Haruko, Miyazaki, Yoshihiro, Doi, Manami, Furuya, Kinji, Takahashi, Kazuhiro, et al. Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial). BMC cancer. 2023. 23. 1. 624-624
  • Yabe, Yoshito, Chihara, Kanako, Oshida, Natsumi, Kamimaki, Takashi, Hasegawa, Naoyuki, Isobe, Tomonori, Shoda, Junichi. Survey of Dietary Habits and Physical Activity in Japanese Patients with Non-Obese Non-Alcoholic Fatty Liver Disease. NUTRIENTS. 2023. 15. 12
more...
Lectures and oral presentations  (27):
  • Treatment efficacy of TACE of balloon-occluded alternative infusion of cisplatin and gelatin particles for HCC beyond the up-to-seven criteria
    (The 83rd Annual Meeting of the Japan Radiological Society)
  • ”Up to seven" を超える肝細胞癌に対する陽子線治療
    (第59回 日本肝臓学会総会)
  • A case of hepatocellular carcinoma in a lenvatinib-intolerant patient treated by BOAI-TACE
    (The 14th International Symposium of Interventional Radiology 2022)
  • 甲状腺癌および肝細胞癌患者における血中レンバチニブ濃度の個体間および個体内変動
    (第38回日本TDM学会・学術大会 2022)
  • Efficacy and safety of cabozantinib in patients with advanced hepatocellular carcinoma: a retrospective analysis
    (JSMO 2022 2022)
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page